Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes
About this study
Decision cycle for person-centered glycemic management is a new diabetes decision making .It is defined as a purposefully designed holistic care intervention .The goal is to improve the self-care behavior of patients with type 2 diabetes, thereby improving glycated hemoglobin levels and delaying the occurrence of complications.
- Condition
- Type 2 Diabetes
- Tested
- Decision Cycle for Person-Centered Glycemic Management, Traditional diabetes self-management education
- Sponsor
- National Taiwan University Hospital
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 11
- Minimum age: 18 years
- Study condition: Type 2 Diabetes
- Patients diagnosed with type 2 diabetes by a physician.
- Age: 18 years or above.
- Glycated hemoglobin (HbA1c ) test value: 7.5-9.0 %
- No diabetic oral medications, insulin and glucagon-like peptide-1 were replaced in the outpatient when the case was admitted.
- No pregnancy during the study period.
- After the researcher explains the purpose of the research, the research subjects agree to join this researcher.
- Those who are conscious and able to take care of themselves.
- There is no diagnostic certificate from the American Psychiatric Association's Diagnostic Manual of Mental Disorders, Fourth Edition (DSM-IV)of all mental illnesses.
- Those who can communicate in Mandarin and Taiwanese.
Exclusion 6
- Patients diagnosed with type 1 diabetes by a physician.
- Age: Under 18 years old.
- Glycated hemoglobin test value: less than 7.5 % and greater than 9.0 %
- Those who replaced oral diabetes medications, insulin and glucagon-like peptide- 1 at the outpatient at the time of admission.
- Pregnancy during the study period.
- Those who are unable to take care of themselves and express themselves.
Where
1 site, 1 recruiting
National Taiwan University Hospital
Hsinchu, Taiwan
Contact
-
Chia-Hui Tsai
886926124093 mtsai0322@gmail.com
-
Kang-Chih Fan
886972654308 ntuhendocrine@gmail.com
Potential match only. Final eligibility is determined by the study team.